Tarun Garg
Title | Assistant Research Professor |
---|
Institution | University of Arkansas for Medical Sciences |
---|
Department | Internal Med, College of Medicine |
---|
Division | Internal Med Hem-Onc |
---|
Address | 9-115 Cancer Institute 4104 Outpatient Circle Mail Slot # 776 Little Rock AR 72205
|
---|
Phone | 501-526-6990 x8482 |
---|
ORCID
![ORCID Icon](https://uams-triprofiles.uams.edu/profiles/Framework/Images/orcid_16x16(1).gif) | 0000-0003-1948-0617 ![Additional info](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) |
---|
vCard | Download vCard |
---|
|
|
|
Research My research is focus on developing natural killer (NK) cells for immunotherapeutic use against multiple myeloma, which has poor outcome despite novel therapeutic agents. In addition, elucidation of resistance mechanisms in myeloma is another area of my interest. Myeloma cells has the ability to evade immune surveillance through several potential mechanisms. Exploration of these mechanisms may lead to develop better therapeutic option in multiple myeloma.
2R01 HL 141408-06 (VAN RHEE, FRITS)Sep 1, 2023 - May 31, 2024 NIH/Nat. Heart, Lung & Blood Institute - Pass Through: University of Pennsylvania JAK1/2 as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target Role: Principal Investigator |
| W81XWH2110601 (YACCOBY, SHMUEL)Sep 30, 2021 - Sep 29, 2025 US Department of Defense Role of novel myeloma subpopulations in the disease progression and drug resistance Role: Principal Investigator |
| P20GM109005 (BOERMA, MARJAN)Jun 24, 2015 - May 31, 2025 NIH Center for Studies of Host Response to Cancer Therapy Role: Co-Investigator |
| 4815 (GARG, TARUN)Jan 1, 2015 - Apr 30, 2016 International Myeloma Foundation Multiple Myeloma Cells Modulate ICAM-3 to Evade Natural Killer Cell-Mediated Lysis Role: Principal Investigator |
| 4815-3004-4449 (GARG, TARUN K)Jan 1, 2015 - Apr 30, 2016 International Myeloma Foundation Multiple Myeloma Cells Modulate ICAM-3 to Evade Natural Killer Cell-Mediated Lysis Role: Principal Investigator |
| R01CA134522 (VAN RHEE, FRITS)Aug 22, 2008 - Jun 30, 2014 NIH Potentiating Natural Killer Cell Anti-Myeloma Effects Role: Co-Investigator |
| 28-06 (VAN RHEE, FRITS)Oct 1, 2006 - Sep 30, 2008 Multiple Myeloma Research Foundation KIR-Ligand Mismatched Natural Killer Cell Therapy for Myeloma Role: Co-Investigator |
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
Don't see publications published under other names? Login to add alternative names.
-
Garg TK, Garg S, Miousse IR, Wise SY, Carpenter AD, Fatanmi OO, van Rhee F, Singh VK, Hauer-Jensen M. Modulation of Hematopoietic Injury by a Promising Radioprotector, Gamma-Tocotrienol, in Rhesus Macaques Exposed to Partial-Body Radiation. Radiat Res. 2024 01 01; 201(1):55-70. PMID: 38059553.
-
Das S, Chander R, Garg T, Mendiratta V, Singh R, Sanke S. Cardiovascular risk markers in premature canities. Indian J Dermatol Venereol Leprol. 2023 Jan-Mar; 89(2):221-225. PMID: 35841351.
-
Garg TK, Garg S, Miousse IR, Wise SY, Carpenter AD, Fatanmi OO, van Rhee F, Singh VK, Hauer-Jensen M. Gamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model. Int J Mol Sci. 2022 Dec 18; 23(24). PMID: 36555814.
-
Garg S, Garg TK, Miousse IR, Wise SY, Fatanmi OO, Savenka AV, Basnakian AG, Singh VK, Hauer-Jensen M. Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model. Antioxidants (Basel). 2022 Sep 25; 11(10). PMID: 36290618.
-
Gai D, Chen JR, Stewart JP, Nookaew I, Habelhah H, Ashby C, Sun F, Cheng Y, Li C, Xu H, Peng B, Garg TK, Schinke C, Thanendrarajan S, Zangari M, Chen F, Barlogie B, van Rhee F, Tricot G, Shaughnessy JD, Zhan F. CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation. J Clin Invest. 2022 09 15; 132(18). PMID: 35881476.
-
Garg S, Garg TK, Wise SY, Fatanmi OO, Miousse IR, Savenka AV, Basnakian AG, Singh VK, Hauer-Jensen M. Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate. Int J Mol Sci. 2022 Apr 22; 23(9). PMID: 35563033.
-
Szmania S, Lapteva N, Garg T, Greenway A, Lingo J, Nair B, Stone K, Woods E, Khan J, Stivers J, Panozzo S, Campana D, Bellamy WT, Robbins M, Epstein J, Yaccoby S, Waheed S, Gee A, Cottler-Fox M, Rooney C, Barlogie B, van Rhee F. Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients. J Immunother. 2015 Jan; 38(1):24-36. PMID: 25415285.
-
Papanikolaou X, Johnson S, Garg T, Tian E, Tytarenko R, Zhang Q, Stein C, Barlogie B, Epstein J, Heuck C. Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis. Oncotarget. 2014 Jun 30; 5(12):4118-28. PMID: 24948357.
-
Stone K, Woods E, Szmania SM, Stephens OW, Garg TK, Barlogie B, Shaughnessy JD, Hall B, Reddy M, Hoering A, Hansen E, van Rhee F. Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levels. PLoS One. 2013; 8(1):e54610. PMID: 23372742.
-
Lapteva N, Durett AG, Sun J, Rollins LA, Huye LL, Fang J, Dandekar V, Mei Z, Jackson K, Vera J, Ando J, Ngo MC, Coustan-Smith E, Campana D, Szmania S, Garg T, Moreno-Bost A, Vanrhee F, Gee AP, Rooney CM. Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy. 2012 Oct; 14(9):1131-43. PMID: 22900959.
-
Garg TK, Szmania SM, Khan JA, Hoering A, Malbrough PA, Moreno-Bost A, Greenway AD, Lingo JD, Li X, Yaccoby S, Suva LJ, Storrie B, Tricot G, Campana D, Shaughnessy JD, Nair BP, Bellamy WT, Epstein J, Barlogie B, van Rhee F. Highly activated and expanded natural killer cells for multiple myeloma immunotherapy. Haematologica. 2012 Sep; 97(9):1348-56. PMID: 22419581.
-
Moreno-Bost A, Szmania S, Stone K, Garg T, Hoerring A, Szymonifka J, Shaughnessy J, Barlogie B, Prentice HG, van Rhee F. Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103. Cytotherapy. 2011 May; 13(5):618-28. PMID: 21171821.
-
van Rhee F, Szmania SM, Dillon M, van Abbema AM, Li X, Stone MK, Garg TK, Shi J, Moreno-Bost AM, Yun R, Balasa B, Ganguly B, Chao D, Rice AG, Zhan F, Shaughnessy JD, Barlogie B, Yaccoby S, Afar DE. Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. Mol Cancer Ther. 2009 Sep; 8(9):2616-24. PMID: 19723891.
-
Shi J, Tricot G, Szmania S, Rosen N, Garg TK, Malaviarachchi PA, Moreno A, Dupont B, Hsu KC, Baxter-Lowe LA, Cottler-Fox M, Shaughnessy JD, Barlogie B, van Rhee F. Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. Br J Haematol. 2008 Dec; 143(5):641-53. PMID: 18950462.
-
Kane CJ, Chang JY, Roberson PK, Garg TK, Han L. Ethanol exposure of neonatal rats does not increase biomarkers of oxidative stress in isolated cerebellar granule neurons. Alcohol. 2008 Feb; 42(1):29-36. PMID: 18249267.
-
Shi J, Tricot GJ, Garg TK, Malaviarachchi PA, Szmania SM, Kellum RE, Storrie B, Mulder A, Shaughnessy JD, Barlogie B, van Rhee F. Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma. Blood. 2008 Feb 01; 111(3):1309-17. PMID: 17947507.
-
Garg TK, Chang JY. Methylmercury causes oxidative stress and cytotoxicity in microglia: attenuation by 15-deoxy-delta 12, 14-prostaglandin J2. J Neuroimmunol. 2006 Feb; 171(1-2):17-28. PMID: 16225932.
-
Agrawal N, You H, Liu Y, Chiriva-Internati M, Bremner J, Garg T, Grizzi F, Krishna Prasad C, Mehta JL, Hermonat PL. Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transduction. Tissue Eng. 2004 Nov-Dec; 10(11-12):1707-15. PMID: 15684679.
-
Garg TK, Chang JY. 15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. BMC Pharmacol. 2004 May 18; 4:6. PMID: 15149553.
-
Garg TK, Chang JY. Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2. BMC Ophthalmol. 2003 Mar 21; 3:5. PMID: 12659653.
-
Sood A, Sharma VK, Garg T, Nair M, Dinda AK. Amyloidosis in Reiter's syndrome. J Assoc Physicians India. 2001 May; 49:563-5. PMID: 11361274.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2001 | 1 | 2003 | 1 | 2004 | 2 | 2005 | 1 | 2007 | 1 | 2008 | 2 | 2009 | 1 | 2010 | 1 | 2012 | 2 | 2013 | 1 | 2014 | 1 | 2015 | 1 | 2022 | 4 | 2023 | 1 | 2024 | 1 |
To return to the timeline, click here.
|
Garg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|